Marcy Komocsar

Marcy Komocsar is a seasoned professional in clinical research operations and finance, currently serving as the Executive Vice President at ProPharma since 2023. They have extensive experience across various roles, including as Clinical Safety Manager and Medical Writing Manager at TAP Pharmaceuticals, and as Director of Outsourcing at Delta Pharma, Inc. Marcy demonstrated leadership as the Global Head of Medical Writing at ProPharma from 2018 to 2023, alongside significant contributions in past positions at companies like Baxter and TerSera Therapeutics. With a robust background in strategic management, Marcy actively participates in sales and business operations while driving operational efficiency in clinical research solutions.